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Background: Over the past decade, the National Action program Diabetes (NAD) was implemented in the
Netherlands. Its aim was to introduce the Care Standard (CS) for diabetes by means of a specific implementation
plan and piloting in several regions. This study aimed to provide insight into the implementation of the NAD as,
coupled with the introduction of the CS, it may function as an example for similar approaches in other countries.
Methods: A series of quantitative studies (participants 2010: N = 1726, participants 2013: N = 1370 & participants
pilot regions 2013: N = 168) and qualitative studies (participants 2010: N = 18 and participants 2013: N = 4) was
conducted among health care professionals (HCPs). In addition, two quantitative studies were conducted among
type 1 and 2 patients (participants 2010: N = 573; participants 2013: N = 5056).
Results: Overall, positive changes in diabetes care were detected in the period 2010 – 2013. In 2013 significantly
more HCPs were familiar with the CS (43.7 versus 37.6 %) and more HCPs perceived themselves to be working
largely or completely in accordance with the CS (89.2 versus 79.0 %) than in 2010. A comparison of the results in
specific pilot regions with the rest of the country revealed that HCPs in these regions scored significantly more
positively on implementation and appreciation of the CS. This positive trend was reflected by the high levels of
reported patient satisfaction and involvement in treatment. HCPs who were in possession of the CS had
significantly better scores on the implementation of several elements of the CS than HCPs who were not in
possession of the CS.
Conclusion: The CS has become more prominent and embedded in daily health care practice. In retrospect the CS
has provided momentum for the realization of various processes relating to the wider implementation of standards
to improve the care for people with other chronic diseases in the Netherlands. Experiences with the NAD and CS
underline the need to move towards an integrated multidisciplinary approach of diabetes care worldwide.
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Diabetes is a multifactorial health problem that requires
a multidisciplinary approach to prevention and treat-
ment. As in most industrialized countries, Dutch health
care faces the challenge of guaranteeing continuity and
quality of care for the growing number of people with
diabetes. For this reason multiple changes in diabetes
care have been introduced in recent years. A national in-
tegrated, programmatic approach to chronic diseases has* Correspondence: lieke.raaijmakers@maastrichtuniversity.nl
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© 2015 Raaijmakers et al.laid the foundation for providing multidisciplinary care
in a seamless manner in the Netherlands [1–3]. Two im-
portant elements of this approach are the Care Standard
(CS) (also see Additional file 1 of the Netherlands Dia-
betes Federation (2011)) for diabetes developed by the
Netherlands Diabetes Federation (NDF) and the bundled
payment approach for financing [3]. A CS differs from
clinical guidelines, in that it is a general framework out-
lining the services and treatment to be delivered to
people with a specific condition on an aggregate level;
clinical guidelines on the other hand describe the con-
tent of medical care in more detail, including what, why
and when care should be provided [2,4,5]. Furthermore,
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(HCPs), patients, researchers and funding bodies with a
specification of the components of diabetes care, general
treatment goals, and tools to evaluate the quality of care,
also including paramedical treatment and prevention [6].
The Dutch Diabetes Association (DVN) and the NDF
have together produced a version of the CS (the Zorgwij-
zer) especially for patients with diabetes, which explains
what they can expect from their health care providers.
In the Netherlands, the CS functions as a general
framework which overarches the guidelines of individual
professional groups and focuses on a multidisciplinary
approach to diabetes prevention and care. In addition,
although not originally developed for this purpose, the
CS is used as a purchasing instrument in the Dutch bun-
dled payment approach for integrated chronic care [1].
This approach has laid the foundation for delivering and
funding diabetes care in accordance with the CS and has
also partly led to the development of so-called care
groups.
Within this approach, insurers purchase the services
and care described in the CS from a general contractor
called a care group, which ends up in a bundled pay-
ment contract. These care groups are relatively new to
the health care system and have been established to im-
prove the quality of chronic care [7]. A care group con-
sists of several health care providers that form a legal
unit. Based on the bundled payment contract, the care
group takes clinical and financial responsibility for all
assigned patients in diabetes care and in turn subcon-
tracts individual care providers (e.g. general practitioner,
dietician, internist etc.) or delivers parts of the services
in relation to the various components of diabetes care it-
self [1]. The Dutch health care insurance system is based
on a ‘semi-free market system’. Health care insurers and
providers can negotiate about the prices of some health
care services. The ultimate goal of this system is that
health care providers are driven to work as efficiently as
possible, and that health care insurers compete with
each other on the basis of prices, without sacrificing
equity, quality and transparency. Most of health care in
the Netherlands can be classified as ‘primary’ care or
‘secondary care’. This care also falls under European law.
Primary care is directly accessible for patients. In the
Dutch health care system the general practitioner plays a
central role in primary care and can be seen as a gate-
keeper who determines whether a patient needs special-
ist care. Secondary care involves care provided by
medical specialists in hospitals. These specialists provide
treatment in an outpatients’ department or to patients
who are hospitalized. Medical specialists are either
employed by the hospital or work self-employed under
contract. Usually patients need a referral from the gen-
eral practitioner when they need secondary care.The Netherlands can be regarded as unique in the use
of Care Standards [4]. The CS for diabetes was the first
one to be developed by the NDF in April 2003 and the
NDF took a leading role in the implementation of this CS
[2,8]. The NDF unites associations of patients and of im-
portant HCPs. In 2007 the NDF started a project to up-
date the CS, which was widely announced in professional
journals and at conferences and through contacts with
NDF members. In 2009, the NDF started the National Ac-
tion program Diabetes (NAD) (2009–2013), the main
objective of which was the systematic nationwide imple-
mentation of the Care Standard [9]. The NAD was con-
ducted with funding (€ 10 million) from the Dutch
Ministry of Health, Welfare and Sport [9]. The NAD com-
prises five subthemes based on an inventory and analysis
of problem areas in the field: ‘Prevention’ , ‘Position of the
patient and client’ , ‘Quality, organization and knowledge’ ,
‘Rules and funding’ and ‘E-communication and IT facil-
ities’. These subthemes are, accidentally, in line with the
concepts of the Expanded Chronic Care Model, a frame-
work that can be used to optimize the provision of care
for patients with chronic diseases, to decrease the burden
of the disease and to prevent its occurrence through
population based health promotion [10]. The model also
advocates integrated care, disease management and the
use of evidence-based care guidelines [11].
The implementation of the CS and Zorgwijzer was sup-
ported by several national communication strategies and a
regional implementation approach in five pilot regions
[12]. The national strategies that facilitated the implemen-
tation of the CS and Zorgwijzer were aimed at knowledge,
attitude and behavior of various target groups (i.e. pa-
tients, HCPs and government, health insurers and em-
ployers) [12]. The main objectives were to inform HCPs
and patients about the existence of the CS and its associ-
ated benefit, and to make the CS easily accessible online.
In addition, the implementation of the CS was facilitated
through the development of more than 50 products which
were related to the NAD themes, based on existing bar-
riers in practice. Examples of these products include the
‘National Transmural Appointment (LTA)’ guideline and
the ‘E-diabetes set’. The NDF selected five pilot regions in
the Netherlands to initially implement several of these
products with the objective of improving them and then
implementing them nationally in the future [12].
Simultaneously with the development and implementa-
tion of the CS for diabetes, the organization of diabetes
care in the Netherlands has undergone several other
changes, which have also influenced diabetes care and
should be discussed here to provide a complete picture.
First, the update of the CS in 2007 coincided with the de-
velopment of the previously described bundled payment
approach [1]. The purchase function of the CS within this
approach is primarily used on the level of care groups and
Raaijmakers et al. BMC Health Services Research  (2015) 15:217 Page 3 of 8the CS has become embedded in the Dutch health care
system as a result of this function. The CS serves as a fi-
nancial incentive in the negotiations with health insurers,
making these more structured since care has to be deliv-
ered and purchased in accordance with the norm. Second,
the bundled payment approach has partly led to the devel-
opment of so called care groups, as previously described.
The CS is used for purposes related to the organization
and quality of care. The care groups often appear to de-
velop their own Care Standards and guidelines, but these
are typically based on the CS to make them more
generalizable to the national norm. Third, over the past
decade, vertical substitution of care has taken place, i.e.
the transfer of tasks between care-providers with differ-
ent levels of expertise [13]. In many general practices
the care for diabetes patients is delegated to specialized
practice nurses or diabetes nurses who are supervised by
the general practitioner. These trained nurses are special-
ized in care for chronic diseases such as diabetes and can
play an important role in educating patients and encour-
aging overall adherence to treatment [14]. Moreover,
standardized diabetes care, delivered by a specialized
diabetes nurse, has been shown to be a good alternative
to standard care by an internal medicine physician or
general practitioner, with comparable results after one
year in terms of treatment goals, and even better results
in terms of patient goals and cost-effectiveness [15].
However, a reported negative side effect of this transfer of
care is that the expertise of general practitioners in dia-
betes care is decreasing [16].
While the NAD was running, a series of quantitative
and qualitative studies was conducted among large sam-
ples of Dutch diabetes care professionals and diabetes pa-
tients [16–19]. The aim of the present paper is to place
this series of studies in a broader perspective in order to
provide insight into the implementation of the NAD,
which besides its evaluative function may also provide an
example for similar approaches in other countries. The
specific research questions addressed in this study were:
1) To what extent are professionals familiar with the CS
and how do they appreciate the CS? 2) What changes are
seen in familiarity with and working conform the CS and
appreciation of the CS between 2010 and 2013? 3) How
was the implementation of the CS evaluated in the NAD
pilot regions? 4) Is possession of the CS associated with
better quality of care? 5) What facilitators and barriers do
HCPs experience in diabetes care?
Methods
In 2010, two cross-sectional studies were performed, in
which questionnaires were distributed among all HCPs
involved in diabetes care [20] (i.e. general practitioners,
practice nurses, diabetes nurses, dieticians, physiothera-
pists, internal medicine physicians, pediatricians andpharmacists; N = 1726) and type 1 and type 2 diabetes
patients (N = 573) [18,21]. In addition to the published
results of this study [18,21], independent t-tests were
conducted to determine significant differences in the
implementation of several elements of the CS between
HCPs who were in possession of the CS and HCPs who
were not in possession of the CS. In 2013 similar
questionnaire-based monitoring studies were con-
ducted among 1370 HCPs and 5056 type 1 and 2 dia-
betes patients [22]. To compare the results of the 2010
and 2013 studies, two sample t tests were used to test a
selection of questions with average scores. In addition
two proportion z tests were carried out on a selection
of questions with percentage scores.
In addition, 18 semi-structured interviews with HCPs
working in primary and secondary care (i.e. general practi-
tioners, practice nurses, diabetes nurses, dieticians, physio-
therapists, internal medicine physicians and pharmacists)
were held between November 2010 and January 2011 [16].
Participants were randomly selected from the database of
the quantitative study conducted among HCPs in 2010
[17,21]. The results of these interviews are already pub-
lished [16,18]. In March and April 2014, four semi-
structured interviews were held with directors/managers of
care groups or collaborations of health care centers. Data
of these interviews were not previously published and ana-
lyzed for the purpose of this paper using the NVivo quali-
tative research software package, version 8.0.
The implementation process of the NAD products in
the five pilot regions was evaluated by means of focus
group interviews among HCPs and the region coordinator
involved in the implementation of several NAD products
in each region. In addition, one focus group interview was
conducted with the NAD implementation team to assess
success and failure factors related to the implementation
of the NAD products and one with the developers of one
of the core NAD products (i.e. e-diabetes set). In total
seven focus group interviews were conducted. The ques-
tionnaire study among HCPs in 2013 was also conducted
among HCPs in the pilot regions (N = 168). The results of
these studies were only reported in Dutch [23].
For a detailed description of the recruitment and
measurement instruments of the separate studies we
refer to the studies of Raaijmakers et al. [16-18,21] and
Martens et al. [19,23]. Ethical approval for the included
studies was not required under Dutch law [24]. This
paper adds to the already published results (in Dutch) of
the studies described and additional analyses on the data
were conducted which are not described elsewhere.
Results
Implementation of the CS
Overall, positive changes in the implementation of the
CS and diabetes care were detected between 2010 and
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were familiar with the CS than in 2010 (Table 1). Add-
itionally, in 2013 significantly more HCPs perceived
themselves to be working largely or completely in ac-
cordance with the CS and more HCPs considered the
CS to be largely or completely the norm for high quality
care. We also found significant differences with regard
to the implementation of specific elements of the CS
(Table 1) [22].
The positive trend among HCPs was also reflected by
the results of the studies among patients. Overall, dia-
betes patients were satisfied with their contact with their
caregiver(s) (mean scores ≥7.8 (scale 1–10)) and per-
ceived a high degree of involvement in their treatment
(mean scores ≥4.1 (scale 1–5)); no significant differences
were detected in the 2010–2013 period. Patients’ famil-
iarity with the Zorgwijzer had significantly increased by
2013. However, the Individual Care Plan (i.e. an integral
part of the CS which supports patients in their self-
regulation and consists of mutual agreements between
patients and their care givers about the goals of diabetes
treatment) appeared to be used less often in 2013 [22].Implementation of the CS in the NAD pilot regions
The comparison of the results of the questionnaire study
among HCPs in the pilot regions with the HCPs in the
rest of the Netherlands revealed that HCPs in these re-
gions scored significantly more positively on possession
and appreciation of the CS than HCPs in the other re-
gions (Table 2) [19,23]. Furthermore, HCPs working in
the pilot regions perceived financial, legislative and regu-
lation issues significantly less often as a barrier. They
more often provided information and education about
lifestyle to almost all or all patients and more often
thought diabetes care had strongly improved [19,23].Table 1 Significant differences in the implementation of the CS bet
Health care professionals
In possession of the CS
Working largely or completely in accordance with CS
Regarding the CS largely or completely as norm for high quality care
Providing education and information about lifestyle to almost all or all patien
Structural collaboration of HCPs in secondary care with primary care
Involving all patients in their treatment
Register quality indicators
Patients
Familiarity with the Zorgwijzer
In possession of an Individual Care Plan
Note: all differences were significant on p < 0.05 levelPossession of the CS associated with better quality of
care
Possession of the CS was shown to be associated with
better quality of care. Professionals who were in posses-
sion of the CS (2010: 37.6 % versus 2013: 43.7 %) had
significantly better scores on the implementation of sev-
eral elements of the CS than HCPs who were not in pos-
session of the CS (Table 3).Perceived facilitators and barriers in diabetes care
The semi-structured interviews revealed several facilita-
tors and barriers perceived by HCPs in diabetes care
[18]. One of the major facilitators was the more promin-
ent role of the practice nurses and diabetes nurses in
diabetes care, as a result of the substitution of care.
Other reported facilitators were benchmarking and
multidisciplinary collaboration, although there is still
room for improvement in collaboration with certain pro-
fessional groups (i.e. dieticians, physical therapists and
pharmacists), and between primary and secondary care.
The bundled payment system for the funding of diabetes
care and the role of the health insurers were perceived
as major barriers within the health care system. Other
important barriers reported by HCPs were the lack of
motivation among patients and the lack of awareness
among professionals of lifestyle programs and preven-
tion initiatives for diabetes patients [18].Discussion
Before interpreting the results of our series of studies,
some methodological considerations need to be made.
The cross-sectional design of the questionnaire studies
in 2010 and 2013 conducted among HCPs and patients
excludes causal interpretations of the associations be-
tween the study variables. Furthermore, the results ofween 2010 and 2013











Table 2 Significant differences between pilot regions and other Dutch regions (2013)
Pilot regions (%) (N = 168) Entire sample (%) (N = 1370)
In possession of the CS 51.9 43.7
Working largely or completely in accordance with CS 91.0 89.2
Regarding the CS completely as norm for high quality care 38.2 24.9
Experiencing barriers in relation to financial, legislative and regulations issues regarding
care and prevention in accordance with the CS
28.8 39.6
Providing education and information about lifestyle to almost all or all patients 63.8 56.9
Experiencing strong improvements in diabetes care past 2.5 years 26.5 16.2
Note: all differences were significant on p < 0.05 level
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data, which may have led to bias, e.g. through factors re-
lated to social desirability. The strength of our studies
was the use of a mixed methods design in which we con-
ducted qualitative and quantitative studies at multiple
stages of the implementation process, thus enabling tri-
angulation. Moreover, we were able to provide insight
into the implementation of the CS from the perspectives
of both HCPs and patients, and we included large sam-
ples of patients and HCPs covering the full range of pro-
fessions involved in diabetes care.
NAD as best practice
Looking back over the past decade, we can conclude that
the focus on the implementation of the CS, through the
NAD, has had positive results. Moreover, the experiences
with the NAD have also provided us with a great deal ofTable 3 Significant differences among HCPs according to possessio
2010
Providing education and information about lifestyle to almost all or all patien
Involving all patients in their treatment
In possession of a written treatment protocol
Having put down responsibilities and competences in writing
Structural collaboration with(in) primary care
Structural collaboration with(in) secondary care
2013
Providing education and information to almost all or all patients
Involving all patients in their treatment
Use of Individual Care Plan
In possession of a written treatment protocol
Having put down responsibilities and competences in writing
Register quality indicators
Structural collaboration with public health
Structural collaboration with(in) primary care
Structural collaboration with(in) secondary care
Note: all differences were significant on p < 0.05 levelinformation necessary to take further steps in implement-
ing Care Standards for other chronic diseases both in the
Netherlands and elsewhere. Accompanying the implemen-
tation of the CS with a government funded NAD may
have been an example of a best practice. Although the CS
was available before the start of the NAD, little effort had
been put in facilitating its implementation in practice. The
NAD has given the CS the attention it needed to become
widely known and used among professionals and has facil-
itated its easy accessibility. As a result of these efforts, the
CS has become more prominent and embedded in daily
health care practice. The findings of our studies largely
support the approach of the NAD, since professionals’ ap-
preciation and use of the CS increased in the period
2010–2013. Moreover, the implementation of several ele-
ments of the CS significantly improved, with even more
positive results in the NAD pilot regions. This indicatesn of the CS
Possessions CS Not in possession CS
% Mean % Mean
N = 538 N = 894
ts 37.5 33.4
58.5 51.1
4.3(range 1–5) 3.5(range 1–5)
4.1(range 1–5) 3.2(range 1–5)
63.2 49.7
30.9 23.6




3.8(range 1–5) 3.1(range 1–5)
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aware of the position and benefits of both the CS and the
guidelines issued by their individual professional groups.
CS as flywheel
It is also clear that in the Netherlands the CS has pro-
vided momentum for the realization of various
processes relating to the wider implementation of stan-
dards to improve the care for people with other chronic
diseases. Multidisciplinary collaboration, registration,
and use of quality indicators for the purpose of bench-
marking, and substitution of care originally provided by
family physicians and specialists to practice nurses and
diabetes nurses, are a direct spin-off of the focus on
and activities related to the implementation of the CS.
The CS has created awareness of the importance of
these aspects of care for chronic diseases. It seems
plausible that these processes would also have come
about without the focus on and efforts put into the im-
plementation of the CS, but they would probably have
taken much more time and effort. Moreover, the intro-
duction of the Individual Care Plan and the increased
focus on self-management means that the patient is
now playing a more pivotal role in the treatment of
their disease [25,26]. However, the question is whether
changing the structure of care through the CS amongst
others, also changes the care processes itself, since pre-
vious research on the effects of population-based dis-
ease management programs among Dutch care groups
showed little impact of these programs on patients’
health [27].
Lessons learned from the implementation of the CS
Currently there are eight Care Standards covering dia-
betes, COPD, obesity, vascular risk management, cardio-
vascular diseases/TIA, hereditary breast- and ovarian
cancer and Asthma among children and adults. Further-
more, two standards are under authorization, two are in
development, six are planned and proposals for two
more are being explored. The CS for diabetes was the
first to be completed. Experiences with the implementa-
tion of this CS can be used to aid the adoption and im-
plementation of Care Standards for other chronic
diseases in the future. The currently finished standards
are published, but their implementation is not accom-
panied by an approach such as the NAD and appears to
receive less attention than the CS for diabetes. Yet, the
CS for obesity and CVRM are available for use within
the bundled payment approach.
The series of studies on the implementation of the CS
has taught us several key lessons. They show that imple-
mentation takes time and effort. Developing and pub-
lishing a CS does not automatically mean that it will be
used in practice. Partly due to the function of the CS asa purchasing instrument within the Dutch bundled pay-
ment approach for integrated chronic care, many policy-
makers assumed that the implementation would occur
automatically. However, implementation means more
than the adoption and diffusion of innovations [28,29].
Research into the implementation of innovations teaches
us that successful implementation of interventions re-
quires systematic planning during the development
phase and that the interventions should made workable
and integrated in everyday health care practice [30,31].
However, in practice, the implementation of innovations
often seems subordinate to the development of the
product itself.
Organizations currently involved in developing the
Care Standards for other chronic diseases could benefit
from the existing knowledge and expertise related to the
implementation of the CS for diabetes and the facilitat-
ing approach used in the NAD pilot regions. Previous
research into the dissemination and implementation of
quality interventions, i.e. quality improvement efforts,
has recognized the tendency of innovators to re-invent
the wheel instead of efficiently making use of existing
knowledge and insights [32,33]. One explanation for this
seeming reluctance to use existing expertise in the im-
plementation of the CS is that organizations and profes-
sionals involved in the development of the Care
Standards for other diseases were not involved in the
implementation process of the CS for diabetes. As a re-
sult they did not obtain ownership of the CS and a low
level of ownership is expected to hamper the implemen-
tation of innovations [34].
Future directions
Despite the multidisciplinary character of the care de-
scribed in the CS, the CS itself is disease-specific, while
multimorbidity is common among (elderly) diabetes pa-
tients [35–38]. Therefore health care needs to move to-
wards an integrated multidisciplinary approach of
chronic diseases worldwide in which the patient with
one or more chronic diseases is playing a more pivotal
role. Although the etiology, management and prognosis
of other chronic diseases are different, the organisation
and quality of care need to meet the same criteria as the
care for diabetes as disease management strategies are
similar in most chronic diseases. Despite the inter-
national differences in health care systems, there is inter-
national consensus on the goals of treatment for
diabetes and the same type and quality of care needs to
be provided to patients with one or more chronic dis-
ease [6]. The Care Standards and the bundled payment
approach are useful instruments in organising integrated
care and stimulating multidisciplinary collaboration. Fur-
thermore, preventive activities targeting chronic diseases
need to become embedded in primary care and close
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lished within such an integrated multidisciplinary ap-
proach. In 2012, prevention was added to the CS by
means of an addendum. The importance of the availabil-
ity of prevention and care close to patients at a local
level is underpinned by the positive results and experi-
ences with the CS for diabetes in the NAD pilot regions
[19,23]. Achieving local collaboration between preven-
tion, care and other relevant parties involved is ex-
pected to be difficult and depends on several local
preconditions, such as the intentions of current muni-
cipal administrators, embedment into existing policies,
political support and funding [23]. However, the force
of action in multiple environmental settings and
levels, compounded by the collective ability to acceler-
ate and strengthen each other’s impact, can pro-
foundly improve the nation’s health [39]. Moreover,
the community approach to chronic disease preven-
tion has a high degree of generalizability, cost-
effectiveness, ability to diffuse information successfully
through use of community networks, and potential for
influencing environmental, regulatory and institutional
policies that shape health [40].
Finally, the CS is currently mainly supply driven rather
than tailored to the needs of patients [41], while we see
an international and national need to abandon the one-
size-fits-all approach and move towards personalized
care [42,43]. To meet this need in the Netherlands, a
group of experts and scientists is currently - in collabor-
ation with the NDF- working on the development of so
called ‘patient profiles’, a new tool which can help HCPs
to provide personalized care tailored to the needs of pa-
tients with diabetes. Within these profiles treatment-,
personal- and environmental factors are taken into ac-
count when tailoring the care and treatment. The
Netherlands is the first country worldwide that will start
with evidence-based application of patient profiles [44].Conclusion
In general we can conclude that the CS is now firmly
embedded in the Dutch health care system and the
NAD has provided momentum for the realization of
various facilitating processes relating to the implementa-
tion of standards to improve the care for people with a
chronic disease in the Netherlands. The experiences with
the implementation of the CS for diabetes underline the
beneficial value of the ongoing process in which health-
care moves towards an integrated multidisciplinary ap-
proach of chronic diseases worldwide. Furthermore,
organizations involved in the implementation of other
Care Standards are advised to take time to embed these
standards into daily practice and involve the profes-
sionals who use the CS in practice.Additional file
Additional file 1: NDF Care Standard (Netherlands Diabetes
Federation, 2011).
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